Podcast appearances and mentions of chris capre

On today's Benzinga Live:-Ryan Cohen Takes New Stake In Bed, Bath and Beyond-Oil Hits New 10-year highs -Will Bitcoin hit $100k by 2023? GET 25% OFF BENZINGA PRO

On today's Benzinga Live:- Berkshire Hathaway's Annual Shareholder Letter Is OUThttps://berkshirehathaway.com/letters/2021ltr.pdf- The Russian Ruble is crashing- Melvin Capital in troubleGET 25% OFF BENZINGA PRO

On today's Benzinga Live:- We ask the age-old question, Reversal or Bounce? - Super Bowl Commercials - Crypto Market UpdateToday's Guests: Options Mikehttps://www.smartoptiontrading.com/https://twitter.com/OptionsMikeJake Wujastyk Twitter: https://twitter.com/jake__wujastykhttps://www.trendspider.comCheck out Trendspider.com➡️ Enter promo code BZ25 to get 25%Chris Capre https://www.benzinga.com/premium/idea...HOSTSSpencer IsraelTwitter: https://twitter.com/sjisraelAaron BryTwitter: https://twitter.com/aaronbry5Disclaimer: All of the information, material, and/or content contained in this program is for informational purposes only. Investing in stocks, options, and futures is risky and not suitable for all investors. Please consult your own independent financial adviser before making any investment decisions.#Benzinga #BenzingaLive #BenzingaProSupport this podcast at — https://redcircle.com/zingernation-power-hour/exclusive-contentAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

On Today's Show: -Spotify $SPOT vs Joe Rogan-Is Softbank selling its Alibaba position? -Frontier / Spirit Airlines MergerSpecial Guests: -Matt Hammond, Founder of IPOwarriors.com-Scott Sewell CEO of Charah Solutions (Ticker: CHRA)-Jake Wujastyk, cofounder Trendspider.com-Chris Capre, 2ndskiestrading.comHOSTSSpencer IsraelTwitter: https://twitter.com/sjisraelAaron BryTwitter: https://twitter.com/aaronbry5Disclaimer: All of the information, material, and/or content contained in this program is for informational purposes only. Investing in stocks, options, and futures is risky and not suitable for all investors. Please consult your own independent financial adviser before making any investment decisions.#Benzinga #BenzingaLive #BenzingaProSupport this podcast at — https://redcircle.com/zingernation-power-hour/exclusive-contentAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

Today on Benzinga Live: Looking ahead to FebruaryGUESTSMatt Hammond, IPO Warriorshttps://www.Ipowarriors.com Twitter: https://twitter.com/warrioripoPeter Wall, CEO, Argo Blockchain (ARBK)Jake Wujastyk, Co-Founder, TrendSpiderTwitter: https://twitter.com/jake__wujastykhttps://www.trendspider.comCheck out Trendspider.com➡️ Enter promo code BZ25 to get 25%Chris Capre, Benzinga Options Trading Schoolhttps://www.benzinga.com/premium/idea...HOSTSSpencer IsraelTwitter: https://twitter.com/sjisraelAaron BryTwitter: https://twitter.com/aaronbry5Disclaimer: All of the information, material, and/or content contained in this program is for informational purposes only. Investing in stocks, options, and futures is risky and not suitable for all investors. Please consult your own independent financial adviser before making any investment decisions.Support this podcast at — https://redcircle.com/zingernation-power-hour/exclusive-contentAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

Today's Guests: Sean Harper, Kin Insurance CEO, Omnichannel Acquisition SPAC Merger Partner $OCA Matt Hammond, IPO Warriors Jake Wujastyk, Cofounder https://trendspider.com/Chris Capre, Benzinga Options SchoolHOSTSSpencer IsraelTwitter: https://twitter.com/sjisraelAaron BryTwitter: https://twitter.com/aaronbry5Disclaimer: All of the information, material, and/or content contained in this program is for informational purposes only. Investing in stocks, options, and futures is risky and not suitable for all investors. Please consult your own independent financial adviser before making any investment decisions.Support this podcast at — https://redcircle.com/zingernation-power-hour/exclusive-contentAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

On Today's Benzinga Live:-Ethereum/Bitcoin Price Targets-Options Trading with Chris Capre-IPOs with Matt Hammond, Ipowarriors.com-Charts with Jake Wujastyk, https://trendspider.com/Join the Benzinga Options School with Chris Capre...HAVE QUESTIONS? EMAIL rodrigo@benzinga.com or CALL +1 313-960-4061For charts and video visit: https://www.youtube.com/watch?v=GPqef6UXBRIHOSTSSpencer IsraelTwitter: https://twitter.com/sjisraelAaron BryTwitter: https://twitter.com/aaronbry5Support this podcast at — https://redcircle.com/zingernation-power-hour/exclusive-contentAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

Episode Summary:On today's show: To Buy The Dip, Or Not To Buy The Dip. That is the question. Guests:Matt Hammond, Ipo Warriors https://ipowarriors.com/Chris Capre, 2nd Skies Trading https://2ndskiesforex.com/Hosts:Spencer IsraelTwitter: https://twitter.com/sjisraelAaaron BryTwitter: https://twitter.com/aaronbry5Subscribe to all Benzinga Podcasts hereClick here for BENZINGA TRADING SCHOOL Get 20% off Benzinga PRO here Become a BENZINGA AFFILIATE and earn 30% on new subscriptionsDisclaimer: All of the information, material, and/or content contained in this program is for informational purposes only. Investing in stocks, options, and futures is risky and not suitable for all investors. Please consult your own independent financial adviser before making any investment decisions.Support this podcast at — https://redcircle.com/zingernation-power-hour/exclusive-contentAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

Episode Summary:Why Cannabis Stocks Are Trading HigherElon Musk takes a shot at Bernie Sanders$QSR Restaraunt Brands purchases Firehouse SubsGuests:Matt Hammond, IPO Warriors 10:00https://www.Ipowarriors.comTwitter: https://twitter.com/warrioripoCybin CYBN CEO Doug Drysdale 48:00Jake Wujastyk, Co-Founder, TrendSpider 62:00Twitter: https://twitter.com/Trendspider_Jhttps://www.trendspider.com Enter promo code BZ25 to get 25%Chris Capre  https://2ndskiesforex.com/ 93:00Hosts:Spencer IsraelTwitter: https://twitter.com/sjisraelAaaron BryTwitter: https://twitter.com/aaronbry5Subscribe to all Benzinga Podcasts hereClick here for BENZINGA TRADING SCHOOL Get 20% off Benzinga PRO here Become a BENZINGA AFFILIATE and earn 30% on new subscriptionsDisclaimer: All of the information, material, and/or content contained in this program is for informational purposes only. Investing in stocks, options, and futures is risky and not suitable for all investors. Please consult your own independent financial adviser before making any investment decisions.Unedited TranscriptHappy Monday, everybody, the markets are back open. Let us know in the chat. What y'all are watching and trading today. A B here, Spencer with me as always Spencer, how are we doing today?We're doing well. We're doing well. Uh, how do we want on the new intro? I saw I saw a new intro. I think it, I think it's, it's part of the way there. I don't think it's all the way there. Do you want to run with the, uh, part of the way there and new intro, the old intro, or just roll? Why don't we roll? No intro today.Let's just rolling. No intro. This is the show it is starting actually already has started. Somy question may be is what has taken a bigger haircut? My head or my portfolio? I don't know. I mean, hopefully your, your portfolio is not taking too big of a haircut. Considering cannabis stocks are all up nicely today. They are, um, using some of my handy-dandy metrics out of the top five trending tickers on social media.So Reddit, Twitter, all the whole investing sphere, two out of the top five trending stocks are in the cannabis space. Spend six. Guess what those two stocks are. Okay. Okay. Without looking two of the top five trending, trending on social media stocks today, um, Uh, are they both stocks? Are any of them? ETS?Are they both? Stocks is one of them kind of be growth? Nope. Damn. Okay. Oh, for one is one of them Grogan. Nope. One for two. Okay. Is one of them, are they both? Are they OTC? No. Uh huh. A Tilray would be the third, the third guest. So Ray's one of them. I see the other one in the chat sundial. Yep. Tiller and sundial are two of the top five trending tickers.Uh, the non-cannabis stocks in that top five are Tesla, Nvidia and Vivian. Okay. So, um, we're, we're going to talk about all this today. Let's talk about everything so that, you know, Tilray and the rest of the cannabis stocks are up on the news that the Republicans are bringing forth a bill to legalize cannabis in the United States.Um, Spencer, do you know anything more about that bill? Uh, another due to present it today, uh, I got to give the, give it to the Republicans. They just basically just hijacked and one of the key issues on the democratic platform and said, well, we'll take that. Thank you very much. Yeah. They're basically saying, Hey, if you guys aren't going to do this, we will and we'll get the credit for it because it's one of those measures that's widely popular throughout the, um, you know, all voters in the United States.So it's, it's. You know, one of those things that'll be a good, easy political win for the Republican so we can get it through which we will see. Um, but either way, I mean, even if they don't, because then if the Democrats step in and have problems with the bill and they can say, oh, Hey look, it's the Democrats holding up, um, you know, legalizing cannabis, which again is something that's, that's very popular.Um, solar up saying, yeah, they, they want to legalize the profits, but we'll see. I mean, I assume there will be, you know, we'll see if, if there can be bipartisan, um, support and work done on the bill. I'm not very bullish on that. We should probably save this discussion for later on, on this show, because we're going to have a cannabis related CEO, uh, on Doug Drysdale was a CEO of Simon to your CYB N related to cannabis, uh, kind of right.Tangentially. It's the same idea of legalizing a drug. It's the same idea, uh, surviving, um, psychedelics are a few years behind cannabis. Um, in everything, right? In terms of regulatory changes, legalization and capital markets a few years on cannabis. So, um, I would be curious to get Doug's thoughts on all this, but I, that being said, speaking of guests, uh, we skipped it on here.Cause our first guest will be on here joining in, in a minute or so. Um, Matt Hamon from IPO warriors is going to recap, uh, last week in IPO lane and preview what is to come this week in IPO's. I'd be curious to hear how Matt played a reveal. And last week I mentioned our Drysdale, uh, from Simon. That'll be at 1245.Love Jake, would you ask Dick from transporter on the show one and Chris Capri from seconds guys trading on the show at one 30. So do as a favor, hit that like button, tell your friends, tell your neighbors, tell your friends, neighbors, dog. And, uh, we can get ourselves off to a good show today. Good start to the week.So like you said, markets in the green, at least last I checked I'm in the green. You're in the green row on the green. What about Dylan? What about Igor? What about bear for one of the chats? I actually took a little thump ski it's in the red right now, but it looks like it's coming back up. I don't know.Yeah, I know it dropped about a quarter for cent out of nowhere at around 11:40 AM Eastern. So that's interesting that 20 minutes ago, I know we'll keep an eye on that. Uh, Q Q kind of same thing, but yeah, Spencer, so big headline over the weekend was of course, Elon Musk on Twitter, uh, you know, took a shot at Bernie Sanders, which some people love.Some people didn't love. Uh, but, but overall, the, the bigger story here is just Tesla's price action in the last week. Um, the stock let's pull up a chart so we can wait, I'll pull my, while you talk, this stock is down more than 15% in the last week. So we're used to seeing Tesla stock, you know, take rips up.Of course, nothing goes straight up. There will be dips along the way, but usually with Tesla, those are followed by bigger rips. The question is, will we get that bigger rip or what will we see the weakness continue? And Tesla's chart. What is test on a bear market? Is that what this is? Where, uh, let me, I'm going on a different chart here by standard definition of going down 20% or more, um, from its all time highs yesterday in a bear market.Oh my God. Yeah. I mean, we, like I said, we will see, cause a lot of times these dips are followed by bigger rips. And that will be the question with Tesla stock. I think this week will be very, very important to see, um, who knows by the end of the week, we could be back at all time highs at around 1200 or we could come all the way back down to 800.So anyone out there that's trading Tesla, let me know how you are trading it in the chat. I'm very curious, you know, are you, are you playing it with the options? Are you buying the stock? Are you buying the dip? Um, let us know what you think about Tesla, because right now it just seems like there's a lot of wins being taken out of the sale.Of course, Elon Musk has a lot of different reasons to sell stock. Part of it is that if he doesn't sell any now than a lot of his options can expire, um, without him exercising them because you can only exercise so many each quarter. So if he doesn't start doing it now, um, he literally needs money to pay the taxes, right.And, and like, and she doesn't have the money they're there. They're the adage goes, there are a bunch of reasons to sell a stock, um, paying taxes, being one of them. There are only a few reasons to buy one reason to buy. There's only one reason. One reason to buy. Well, yeah, we'll say there's only one reason buy what's the other reason using the one, one reason why talking to.Well, if you're like a inset. Yeah. But if you're say short a stock, you need to buy it to cover. You know, there, there are multiple reasons you can buy something. If you're an insider, like Elon Musk is, and you're going to buy the stock. There really is only one reason because you think it's going higher.There are a multitude of reasons is why you would want to sell a stock. But I think regardless of what that reason is for Elan, um, for Tesla, shareholders and Tesla fans in general, seen him sell stock is a bear sign. So we shall see. But right now, Tesla down about 4% on the day, continuing, uh, uh, bear trend for the stock, which we haven't said in a while.So, um, again, let us know in the chat, how you guys are trading it. Um, etc. Same Tesla just approved to sell electricity and sexist. We'll see if that can be a catalyst for the stock, but who knows, Dave is saying he's buying the dip every time it's on sale. So it has been proven right? Time and time again, buying the dip always works.Isn't that the rule, it always works except in some stocks. Yep. So Spencer, before we get to Matt Hammond, we've got one more headline, this one in the restaurant space. Um, so if you're a, you know, a fan of fast food chains, whatever this may interest you, uh, QSR. Yeah. We know it. Owners of burger king and Timmy hoes over owners of burger king, Tim Horton's, Popeye's just acquired another brand today and an all cash deal, a sandwich.Franchise, you know which one that is Spencer? I, well, I saw the headline, it was firehouse subs. It was $5, billion dollars for firehouse. So some expensive subs. So that just goes to show you guys, if you open a sub shop and you do well and you franchise it out a little bit, you can sell it for a billion dollars.A restaurant brands goes out, buys, firehouse, and then a $1 billion cash meal, uh, you know, will, it looks like the markets like the move for QSR up about a percent, but nothing crazy. So we will see how prior house is able to impact, uh, restaurant brands is, you know, revenue, balance sheet overall, but just some, just some headlines in the restaurant space.That is, that is a, those are some expensive stuff. That's all I'll say by Shelly, congrats to the firehouse subs, seriously, that company donates a portion of their profits to firehouses. So, so congrats to them. Great job. Yeah. Who knows? Maybe they'll stop that. Now that they're under new ownership. I doubt it.I hope not. Um, Shelly pointed out another headline in the, in the restaurant, fast food space. So McDonald's announced a partnership is still relevant. It's about to be holiday season. So every time Mariah Carey she's and it's here, it's here. It makes it come back every year around Christmas time. So we've seen, McDonald's do this with a few other artists have, have, you know, deals.They have one with BTS the popular, uh, K-pop Korean pop band. They have one with Travis Scott. Um, so now they're doing the same with Mariah K. Yeah, I know. So anyway, uh, so we know it's approaching Mariah Carey's season. Uh that's that's in a couple of weeks though. Uh, you know what season is now? It's Manhattan season.It's IPO season. Let's get mad at him and all the total talks to my POS. Is he at? Nah. Hey, I'm doing great. How are you guys doing it is IPO season. Um, we had an off season there and, uh, some, some pretty big ones. So, uh, okay, excellent. I can't wait to hear how you put revealed last week. So here you go. I told you I was going to watch for Vivian, but it did play out what we'll get to that one in a second.Um, first thing I wanted to say is thanks to everybody who contributed to the fundraising campaign. I said, I wanted to get some better streaming equipment. I want to live stream. Some IPOs have been talking with Benzinga they've at least indicated. Maybe we'll do a little bit more switching out to watching some of these actually go live.I think it would have been pretty fun to watch some of what ribbon did, uh, you guys have, you know, talking to Rowan, he's going to kick me out some gear as well. Uh, but we, uh, we got $2,000 in under one week. Um, and I really appreciate all the support. Some of the things I'm gonna use that for is improving the presentation quality of these, uh, kind of weekly shows.I would like to do some live streaming of the IPO debuts. And if time allows, I will do some video breakdowns of the IPO as before, uh, before they go live. Um, really appreciate that. It's not too late to contribute more, I'll buy more stuff and, um, you know, improve things even better. You should have some equipment on the way, man.Yes. So I've heard and I, and I'll ask for some, if you guys have some t-shirts or stuff, I'll wear those on the, on the show and with what I'm doing. So, you know, uh, yeah. Yeah. Well say what's on your waist. Some schwag sweats. Okay. So we actually had a lot of really good ones. Um, we talked about sent a one off 25%.We'll just run through these real quick. I didn't like this as a play. I don't generally like, uh, anything that dumps like that anyway, uh, dumped off the debut. If you did say, Hey, wait, this is below the IPO price. It's dip this far. How, you know, how bad could it get? Um, you know, you were rewarded not just with a retracement up to , which is a lot of times all that we see.Um, but if you held through that and said, okay, well, I'll give this some room to run. Uh, it just for no real reason blew up, uh, head up to 2250. And you know, one of the things about trading is you're looking for, uh, stocks with catalysts. You're looking for volatility. That's what you're looking for in day trading.And that's why I like IPO is not, all of them are going to do this. Uh, but if you have, if you like this company, I guess a lot of people do like this company, um, you know, your catalyst is, Hey, it's IP. Uh, the momentum, the volatility, the volume are all going to be about as high as you can ask for on the days that they IPO, which is what make these attractive targets for a day traders.So St was one society pass. If you remember last week, I said, Hey, this kind of, you know, a crappy, uh, Asian e-commerce ish, you know, S IPO that really looks sort of weird with a pretty low float. This could be a stealth IPO. Um, I tried to get in on this, and unfortunately we will hit the indication price rate before it debuted.So I had mindset at 1350 and it debuted at 1550 and then dropped to 15. So if I had been a little bit more aggressive out of caught this ride from 15 through four halts, top tier, like 42 or something, um, came back here around 30 and we see these just run the same pattern, ran up to 52. Uh, the next morning ran up to 70 and we saw these with thanks.Uh, C pop, um, TRS. Why do you suppose that is? I don't know if we've ever, if I've ever acted that before. Yeah. So there's different theories about this. Um, Having talked about it with a bunch of people and putting our heads together. The thing that makes the most sense to me is that, you know, whoever's buying it way up here is not trying to buy low and sell high.They're almost like trying to buy high and sell low, um, or really just buy high and not give a crap. I was going to say, buy high and sell higher. I thought, well, I mean, who's buying, I mean, they are pushing this up through halts on day two, you know, and somebody paid somebody up at $60 for a garbage company.I mean, we saw EJH was one of them that did this and it's like a cleaning company in China. Uh, w and w which spiked yesterday through some Holtz off some random, I mean, they're, they're low float to begin with. They tend to try to do things to deter us from seeing them or for wanting to play them.They're so bad that, um, you know, no one in their right mind is going to pay this thing. The IPO price was a $99, you know, who is going to say, okay, well, this company has no revenue or barely any revenues. The, uh, the, the platforms that they run are garbage. Uh they're they're just losing money. You know, who's going to pay $15.It's so bad that it's good. It's so bad. That it's good. That's what I think. I know. I mean, my, my answer and for this until proven otherwise is that they're all, they all have ties to China. I mean, we saw FCU. The was a uplifting. They all have a similar on underwriters. This one was max. We've seen a lot of them that were, uh, boasted securities.We saw a bunch that were network one financial Sutter, and a lot of these companies have done IPOs together. They've co-written, um, you know, been the co-writers on IPOs as the underwriters. So there's sort of like, they must happen my theory and they use the same lawyers and they have, uh, my opinion is that they're helping Chinese and other wealthy Asians, especially Chinese follow money out of China.So if you have a whole bunch of money in a bank account in China, and you're trying to get it into Hong Kong or Singapore or into the Western markets, what you can do is you can issue shares somehow out to, you know, if you can hand shares cheaply to your cousin or your uncle or some affiliated partner outside of China then, and just tell them, Hey, I will control the, you know, control it, just control the float.And I will buy, you know, as much of this stuff as I can, uh, with this say $200 million I have in a bank account here in China, you know, that money as I buy those shares that no one else has no. You know, who else is participating in this market? Not a lot of people. So if I'm the only one buying your shares, I'm basically giving you that money and moving that money from China to, um, you know, to the west.And I talked about last week, pets, pets was one that I had called out a month ago and sent out to my newsletter when it was about a dollar 30 or a dollar for. Because they had the same underwriter do a direct offering of 30 million shares basically at about 60 or came out to about 30 cents a share when you factored out the warrants and the profits.And you're like, well, that should just sink the share price, but it didn't, it did a little bit, um, but it came right back up and now it's up at $6. You know, it was at $4 when we talked about it on the show last week. So why are they doing this? Why is hoodie H UDI? Why has that got to $45 in the last, you know, few months?Why has, why did TRX go all the way up to a hundred dollars? And then in one day lost 90% of its value with, you know, with no headline, no new news, no nothing. Um, why does, uh, w and w sometimes randomly pop, why do, uh, you know, why do these go well? Because in my opinion, they're moving money. They're using these as vehicles to get money out of Asia and into, you know, Western markets and the seat after, after this happened, I went back and said, geez, you know, Y you know, what, what did I miss here to not make me just put my limit order at like 16 or 20 for that matter?And I went back and I looked up, the CEO is, you know, extensive experience doing startups in Shanghai. The CFO, you know, is Chinese. So, um, you know, there are hands FCU V when we look back at it, we said, oh, we had our eye on it. And it took a day before they ran it from like five or $6, all the way to 25. Uh, in one day after their up listing, and then now it's come way back down, but what was up there?Oh, the whole, like the only three employees are all very, very Chinese as in, they don't even have American alias names. They're Chinese engineers. So this tie back to China, and that makes sense if you're a wealthy Chinese person with tons of money in China right now, given what, you know, president Xi is doing over there, he is basically cracking down on the wealthy and if I was a rich person, uh, or a rich person in China, more specifically, I would be trying to get my money out of there too.And it's not easy to do that. So even if you're paying a 30, 20, or 30% premium on the shares that maybe get bought out or sold by other people, um, and this is an effective way to, and it's not the first time that the stock market has been used as a way to funnel cash out of a country. The Russians were doing this in the nineties.Um, and that's, that's the only answer that I have. How does, you know, how do completely garbage companies make insane runs? Uh, that all of a sudden, I mean, this one's still kind of holding on, but I don't, it's, it's, it's nowhere near any reasonable valuation and all of these tend to Peter out, or they all do Peter out eventually.And when I look at pets and what they're doing there, I'm just like, okay, I'll just, I sold enough. You know, I bought in at basically a dollar 20 and I sold enough when I reached eight on one of these days where it gets by. That I've already paid for my position. And now I can just sit back and if they run it, I think they're still running it because it hasn't fallen out yet.And when it does fair enough, fair enough. Anyway, I try to call these out when I I've made huge profits on some of these, uh, I made 30,000, $33,000 on a thousand shares of TRX. When it debuted, it went opened at 17, went into a three-hour hall and opened up again at $50. You know, so if you can spot these and you take kind of a, okay, well, you know, I'll, I'll give it a shot approach to it.I mean, the, the returns have been massive. UTME that was another one. Anyway, back to the more traditional kind of fun and boring ones that are also profitable. If you play them right. Expensify, we said we liked, uh, we got in here at the debut. I do like taking a $2 profit rate off the run. Um, it's sort of, kind of the easiest, I would say two hours and trading is defined a good, you know, a good company with these guys had to have a positive baseline financials.They're somewhat brand recognized the float wasn't too big and it gave you exactly what you expected right off the debut. So you buy a thousand shares, get in it, you know, say 39 75, sell it at 42. That's like a really pretty comfortable, easy 5% win, uh, right off the bat. Uh, the market. Wasn't really rewarding.These IPO's on day one, the way that we've seen maybe three or four weeks ago. So this one pulled back a bit. You could try to double dip. I generally don't do that. Uh, but where the real money was in these plays and I'm taking notes for kind of the next set of, uh, of IPOs is a, these day two runs. Uh, this one actually touched $50 today.You talked about that a lot. So especially for brand name IPO's, a lot of people are starting to kind of come into the IPO. I'd say that the number of followers I've got has been much higher over the last two weeks than the, you know, the previous six months. And I think a lot of people are keying in on it and it's, in some ways you have to adjust because if everybody's buying in pre debut, that's less demand once it actually goes live.But a lot of people are kind of catching that overnight media cycle where the, you know, the headlines say, you know, Expensify pops 50% on its debut, and they're not talking about this move. They're talking about the IPO price was like 18, and then it debuted at I. Yeah, I, and you know it, wherever you can do the same thing.I I'm hoping we can get to that because I, I was taken aback at the ferociousness of the day to run in green river. And I guess I shouldn't have been, but I was cause. Because it seemed to go straight down, skip through the, to that one that, or, you know, black ways, again, $2 taker just right on the debut, $2 in your out hole, you know, and you can hold these and they come back in.I wanted to show you one thing about holding IPOs. And again, I don't consider playing a debut to be super risky is, um, okay. People who played this cocoa water, uh, you guys were talking about it this morning and that was a, it was actually not a good debut play. Uh, and which is why, you know, when people ask me, oh, what do you think of this company?I'll say, well, you know, for a long-term position, I don't, I wouldn't suggest buying debut. Um, but you do want to start watching it then, because then you kind of know where it's ranges, where it trends. But if he did say, oh no, this one's going to do great. Uh, everyone loves it. Uh, I'm gonna, I'm going to buy the debut and you got stuck in it and you didn't get any kind of day to run.I've held IPO debuts for, you know, usually it's about a month before you're gonna see what it's going to turn around or not. And the catalyst you're looking for after the debut is the end of the media. Um, or the, uh, press release kind of silence, period. I guess they call it. And the first earnings report.Now, these guys happen to come in with a very strong earnings report. And if you had liked this company enough to buy the debut and you have the conviction to buy it there, why not hold it here? See what it does. And. You know, today you finally gotten, you know, today was the first day after a month, basically a trading that you got an opportunity to take your profits.Do you stop there? Probably I do. If I'm holding a bag and I'm given the opportunity to cut it for a non loss, I'm out, um, very rarely will I hold longer than a day to have it come back and then say, no, I'm going to get greedy. Uh, that's only hurt me when I've tried to be pigs, get slaughtered anyway, a vaccine city by the halt, uh, by the debut, this had a ton of buzz, low float, sell the halt right there.Easy as pie and take your profits. Say thank you. Uh, derm debut below. Where did I put ribbon? Okay. I would love your thoughts here. Cause it seemed like he just went straight down and I, and I want to pull it up on, um, give me a second. I'll pull it up and we can look at the, uh, the chart here. So ravines pretty much exactly what I said.It would do two things. One, I had just taken a win on a. What was it? The, uh, Backblaze or the one before that was earlier in the day and after take a win off and just be like, okay, that's the one I wanted. I am, you know, I can try to keep playing more, but I ended up starting to make bad decisions and, uh, try to control against that.Uh, Ratheon was on one hand, a great a, you know, I mean, how much more social media buzz and momentum could you ask for than any V play when Tesla just broke a thousand and it had a lot of other great, uh, you know, I had a lot of good storylines to it. The Amazon deal it's Ford as an investor, um, but had a huge float and I don't like huge floats the floats 153 million shares.And we S I think I said on the show that it reminded me a bit of snowflake and Coinbase. And my, and my, uh, theory was that we'd get about 10, 15 minutes of upward momentum and then correction, which is exactly what we saw. And for me, I'm not long EVs. I still think that, you know, at some point in the not so distant future, the market is going to realize that selling vehicles is only so profitable that not everybody, um, is just going to buy one model.And, uh, you know, they got supply chain issues. It's just the valuations on these don't line up with what automobiles have traditionally sold for. And I think eventually we see that I don't know when it's going to happen. Clearly it wasn't this week. Um, w I did, you know, so I was in the gym and I was watching, you know, ticker in between sets.And when I saw it kind of come here, I think I'd got off my run and it was a hundred. I thought I already missed that dip here, but, you know, maybe that's the, maybe that's the place to buy for the day to media run, because this is clearly going to get a ton of media hype. And then it started moving down again.And I kind of said, um, maybe, you know, maybe it's not as hard as I thought it was, but clearly if you saw this and bought in for the day too, and I mean, you're in an excellent position. It's a one, I mean, Clayton has pointed out. I, I, I, I lost sight of it. Yeah. I mean, w w w we did, we hit one 50. Yeah, we did.We hit one 50. Holy cow. Holy moly. So if I had pulled that day, you know, that day one trigger down here, I would have sold it, maybe one 20. Anyway, I just don't like I went through over the weekend. I went through and I really needed to do a bit of a self evaluation of Metro. And I make so much more on IPO and sort of like, you know, I like to stack guys like Mitch, uh, and the, you know, the blanking on his name there, the guy that does the, the selection.I mentioned Chris. So they have, I mean, the, the, the, the amount of money that they've made for traders in their spec, like the spec catalyst to me, is kind of similar to the IPO. It's like, you know, what's coming up, you know, that it's going to have a merger vote, you know, that it's going to DCE back and become, you know, a name and that's going to be immediate, you know, the next door.That was pretty obvious media catalyst. And I went from like 11 to 18 in one day. Uh, so these, you know, I like specs and IPO's because no, where, you know, it's so easy to time what's going to happen with everything else in FDA announcement, that's going to come off market. Or, you know, whoever gets the news first is going to get it.And some, a spike right up, you know, you don't know that that's coming or these other plays. And I looked back and I just I've done so well on these words, swing trades, where you're trying to find the bottom and, you know, read the trend and you have to wait, you know, a long time to make your money.Whereas an IPO, I want to make money in like one or two days at keep my, you know, my money in cash. You know, the market can crash one day and I'm not exposed. And I'm just in a, to me, it's it fits my style. Uh, if you can't sit there and play these in real time, would your screen all day, you know, then it's not a great trade.If you're good at day trading and reading charts and all that stuff, you know, maybe that's better for you. I'm not. Uh, I ended up, you know, with a long list of bags, waiting for them to turn around. I like to get in, get out, hold for one or two days, maybe three, if I really think it's hot and maybe I should have read this one a little bit more.It's also, is it a price where it could come down a lot more as well? So, um, never been great with EVs, but we'll see this week, there's a lesson to take forward from this week that maybe we will, uh, be able to catch. So, um, let's, uh, jump through affinity. I think we've recovered, uh, covered those. So this week's featured IPOs.Do you want to say anything more about ribbon? No. I was just curious to hear how you played it. I mean, I sorta lost sight of it today, so I was surprised to see it at one 50. I realistic. I felt like going in, we were, we were Jones in for, for a rock pole on the way that was wrong. That was wrong. Uh, but it just sorta had those vibes near, but Hey, sometimes the obvious place to play.So, uh, what do we have this week? Ooh, she was asking me when I became a speck fan. Uh, the first fact that I really banked money on was, um, what was that? Uh, Nicola. So I've been in SPAC since pretty much the second one. That was it. That was the second big one of this. Yeah, that was yeah. After fan do. And I got FanDuel like the day after it disrespect or not FanDuel or DraftKings drafting.So I got, I got dressed and that was like, I didn't really know what a SPAC was. And I think a lot of his back was that in, in may of 2020, so that put them on the maps, put us up, put us on the map. And since then I've played a TMC Michonne. Uh Chris's you know, uh, I got high on cue. I got, uh, they're they're, they're a handful they've been, they've been pretty good.Uh, and it just, you know, don't get greedy, take your profits and, uh, you know, look for the next one. I'm actually almost always sell out, but by the time I see, you know, 20 to 30% up, I'm just like, yeah. So thanks, bye. You know, and, uh, raise up the cash. And then they run up to like a hundred percent gainers, but that's okay.My room, I have two rules and trading. They are, uh, written here. So I don't forget. They are take like you can't read them, take profits without regret. And don't chase. Those are my two rules. As long as I stick to those, every time I break those and get myself in trouble, when I stick to those rules to do pretty well.You got the calendar. I saw one, the other jumped out to me, but so, so let's run through the boring ones. Sure. Uh, sonar group is not so boring when you consider solar coding for. And they do have, this has sexy all over it. Yeah. And they have, so they don't have any revenues, no point in going over financials, they do have 50 million in customer deposits for their sign-on vehicle.Um, as I understand, those are deposits that, uh, I don't know what the refundability is on those, but when you combine two hot, you know, you're talking about eco solar and Evy and that's, you know, how, how much more do you want there? Right. And you can't put Bitcoin in it's can you, um, so not, yes. Yeah. Right.But you can buy with Bitcoin. That would be the next catalyst. Um, but, uh, yeah. Uh, they, if they mined Bitcoin with the spare solar power, then maybe you could, you could pump this up even more than it is, but this is about as much, um, kind of hype buzzwords. You can cram into something right now. And I got to try this one because, you know,yeah, Wednesday, we don't have any until Wednesday kind of a little bit thinner week. This week, Iris energy. This is a Bitcoin miner. Uh, they don't hold Bitcoin on its balance sheets apparently. But if Bitcoin, how is that possible? Uh, maybe they just sell it right away. I'll on mine and they sell it. Okay.That's something new. I gotta, I gotta research a little bit more, but they do have positive cashflow and operating profit, which leads me to believe that they are selling these, um, And they're basically they're using IPO money to buy more hardware. So if they're successful in mining, why not scale up? Uh, especially when the price of Bitcoin, at least a lot of people believe it's headed to, um, you know, to a hundred thousand.So if the, unless Bitcoin crashes before Wednesday, uh, this looks like a pretty hot play. S D I G, and a couple of the other, all the other Bitcoin IPOs have done pretty well. So 8.27 million shares. That's pretty low float. I like this. Uh, you know, the trend is your friend Bitcoins are trending. So we got my point, right.With all these IPO's. So we've got Wednesday, Thursday, Friday. None of them have priced yet. Right. Do we have an expected w we have the ranges, but we don't have the pricing until, and the pricing can change, especially for the hot ones can change dramatically. Can you give the range on these if you have them?Okay. For, I don't know, they might've pulled as C S E V already. That's too bad. Let me see a Sono price range. 14 to 16. Okay. Um, we've got, uh, IRN 25 to 20. So for the hot ones, we often see them get bumped by, you know, a dollar or two price out of range, a price at the high end and things start pricing at the low end then, unless, you know, if you get a discount to that then, okay.Maybe that's interesting. Uh, in other words, the debut comes live below the IPO price. That's been a pretty safe, uh, play, as it works its way back up to the IPO price, you would expect not a lot of IPO price, uh, buyers are selling, uh, for an immediate loss. So, um, but kind of pricing in the middle that has not been a very good, a sign of strength and I'm generally sitting on the sidelines for those.Okay. Um, but yeah, I mean, solar, Evie, and Bitcoin to lead off the schedule, those, you know, once they should be fun, uh, user testing, this is a platform for companies to test user engagement processes. Uh, maybe it's a good business revenues up 44% last nine months gross profit up 51%. Um, but negative cashflow, negative operating loss, negative income.This is kind of just one of those SAS plays where I've never heard of this company before. It reminds me a little bit of this company was like internet advertising program IAP or something. I don't know the. If you, if there's no brand recognition, they have to be really strong to get, you know, people to come in and buy them.And there's also a sort of odd follow on offering lurking in the, this is not the, it's not a lock of expiration, but they have the right to sell an additional 27 million shares. If the price is 10% above the IPO price, you know, it's something like over 10 days in the previous week or something like that, the point is that the debut price will likely be over 10% to begin with.So if the IPO price on this is, uh, 15 to 17, let's say they debut at 17 or 18, and then it actually debuts at 20. So if they IPO price at 17 or 18 and debut at 20, you already at that 10% level, and then it's, it's think it's a hundred days or something 90 days, then they can, you know, then they can sell them 27 additional shares, which almost doubled, you know, it's more than doubles the float.And I don't really like it when I see those kinds of things just gives me shivers, like remembering what coping had hidden in its, uh, lockup period, which was probably the worst IPO I can recall. Um, playing that was the day was you'd have like 60 or 65 and miss now at 27 and never even gave you like a.Courtesy rebounded any point, really? It just was a downward downward dumpster fires. Alright, super interesting here. Um, res, now this one is, I mean, a similar customer engagement and communication. Revenue's up 2.6% gross profits up 60% again, negative baselines. And unfortunately it comps to Weaver, which last week did not do well on its debut and brace has a higher valuation, but I think it might appeal to more businesses.So I don't know, 8 million shares. It's just, I don't feel super good about these. And given that there are others that I do like more this week, I probably just let these pass. I can't play every single IPO. There are people who have that approach, you know, for them and they really manage those trades.They're better at day trading than I am. They buy on the dip and just hold it for ever sometimes. But, uh, this one to me, both of these sort of user cutting and Braves, both in customer engagement, if user testing, somehow those, well, maybe that changes my opinion on Brays, but I'm looking forward more to this one.It's a sweet garden. Now we talked before about how restaurant chains have done really well on their IPO's. And I kind of include bros in that, uh, you know, in that group because it's a chain. It does well on. You know, on a limited number of locations, the theory being well, if you raise a bunch of money and expand it nationwide, it'll do even better.So this one is like, kind of, I guess they say plant forward, which I read as vegetarian, but I guess they probably have some meat in there somewhere. Maybe they do. I'm a little bit deeper. I'm not a vegetarian, but Hey, you know, everybody wants to go out to eat how they want to. But, uh, interestingly, they acquired this company called spice food and this company looks pretty interesting.They're basically like a robotic powered restaurant system. So you're kind of getting a technology angle on a restaurant chain and given what bros did given what Portillo's did even, uh, F w R G, which is some, you know, breakfast restaurant that I'd never heard of a chain has done, you know, did well off of its date, IPO debut.So these guys are article last week that robot sales like industrial robot sales are at an all time high. I didn't see that. And that, and that kind of makes me feel like this is in alignment with some of the trending topics in the market right now. Okay. So the rebounding out of COVID revenues up 50%, I mean the revenue numbers mean nothing.We've talked about this before. If you're going to compare how a restaurant did for any P you know, the last six months, nine months, 39 weeks, whatever, uh, to the year before we're still making comparisons to. And I just kind of have to throw those out the window, uh, negative cashflow, net income, and operating loss.I don't love though to see that in a restaurant industry, others have been, I think a, you know, Portillo's was, you know, positive and its financials. Um, but I said, I don't want, I'm not going to miss the next chain restaurant play and, uh, bros, Portillo and F WRG. They all did well for IPO's it's 12.5 million shares.It's got healthiness to it. It's got the sort of, and although, you know, Oatley did badly today and beyond meat hasn't done well, there is still a demand for in health forward plant forward eating. And I want to give a, you know, I want to give a restaurant chain, um, you know, I'm going to stick with the trend there and try the rest of the rest.Ha ha healthy food. Alternate is not hot right now though. So, well then maybe we get a reasonable entry price on this as well. All right. That's the glass half full approach. Okay. Fair enough. KinderCare. Yeah, the main thing is just again, so KinderCare learning, um, education centers, blah blah, blah, 1500 locations reopening momentum.They make revenue. This is something this should not be allowed to be a public company. I'm sorry, just to not, no, no. Forget to forget that this should not be a for profit. Like childcare in the, in the U S is so unaffordable. And now we have companies that are going to be publicly traded. They have to answer to investors and the answer to wall street about their stock price and their, their margins and their, and China just made that move a few months ago and killed all the private.This should not, I, this I, that might not be a popular opinion, but I mean, this should not be a publicly traded company. I missed we're talking about childcare, whatever. Just tell us, tell us about the IPO. Ah, yeah. W gross profits are up 3534%, but again, we're talking about comps to lock down, so I can't count much in there.They do have positive baseline financials. So cashflow income operating profit are all positive. So it's a big company. I mean, you're talking about 1500 locations and I mean, we're a capitalist society. If our social different socialistic approach to working, you know, the private market's gonna, you know, is the only, it's our only hope of we can otherwise we're just gonna have, you know, who's going to be the educated future.I mean, I agree with you. I th but we're talking about the holistic approach. We have the socialistic approach to K through 12. It's just pre-K that people versus this is ages six to 12. So this competes with, um, with public school. Okay. Yeah, I do six to 12. I think it's a lot of like preschool and afterschool.I kind of skipped over because I just sort of like, nah, maybe this company is pissing me off next change the subject. All right. Six weeks to 12 years old. Oh, six a week. Wait. Okay. Whatever I, I w oh yeah. Yeah. We've been filling a need there. I have an 18 month year old kid and a child. And, you know, there are days when we would like to just put her in someone else's care if we found someone trustworthy.I bet. All right. Um, no, I love my daughter. I love spending time with her, but it's a lot better. Anyway, uh, Austin gold, this one is sort of like, Hmm, well maybe, uh, it's a gold exploration company in Nevada with corporate offices in Vancouver. Uh, they are revenue, which means they basically just are exploring right now.And the website is horribly lacking. Uh, it looks like something a kind of intern might build as a test project and a web development company. And for me, that's a red flag. I, uh, you know, I mean there's pages where it says like, uh, error content missing on their press releases. Uh, their investor page is basically blank.Um, and since I am a designer developer, I do find that, especially for these sort of low float under the radar IPO's unless I'm looking for it to be terrible. Uh, not having a strong, solid website is sort of like, I don't know how seriously I can take this company if, um, you know, if they don't even have an updated website, uh, I want to I'm with you.One interesting thing though, is that, uh, some people I know who have some knowledge of Nevada and gold mining said that these guys are operating before areas that they're operating in are the right areas to be operating in. Um, and the CEO just last week sold his previous company for $2.8 billion, which was it's really M resources.And he sold it at a, something like a 30, 40% premium to the share price. So Cheryl, you know, shareholders are happy with that. Uh, the float is 3 million shares, but Roth capital is not a particularly loved underwriter. Uh, they must've done something. I still haven't nailed it down, but they have sort of a reputation for screwing, uh, IPO buyers and people tend to avoid them.Um, we've also seen a lot of their, IPO's just seem to get terminally rescheduled and we're up against the clock. We, we, we got, oh, that low. We're on time. Yes. Awesome. That Hammond runs IPO warriors joins us every Monday to run through the weeks late an IPO. And we appreciate that Matt, or as a pleasure and go to the newsletter.I get the newsletter. I feel warriors.com. I'm going to start adding some more, uh, kind of featured breakdowns on individual IPOs. Um, my kind of longer-term vision is to have time to make videos, to put on there as well, to break down some of these with a little bit more in-depth analysis of the actual financials, uh, when I'm reading on Twitter, that kind of thing.So, uh, stay tuned, sign up for the newsletter. Follow me on Twitter. Thanks guys. Have a good week. All right, let's keep it going here. Our next guest has been waiting patiently backstage dog Drysdale. I've mentioned him at the top of the show. He was the CEO of Sayven ticker. CYB N a B. It's bringing him on the show.How are we doing Doug? Happy Monday. Thank you for taking time out of your day to join us here on Benzinga live. How are you doing today? I'm doing great. Thanks gentlemen. Thanks for having me today. You're welcome. So real quick, before we get started for some of our audience that may not be familiar, do you mind just giving us a quick rundown of what it is that Simon does and what the mission is there?Yeah. So Simon is a biopharmaceutical company and we're working to transform psychedelic drugs that we've known about for decades now into actual therapeutics for mental health disorders, like depression, addiction, and anxiety disorders. Got it. So last week, I know we saw some news about M C Y B 0 0 3.So that's one of your guys's PR proprietary drugs. Do you mind just overviewing that news real quick? Yeah. Last week was actually an historic week, uh, in the many decades that people have been working on trying to transform these molecules into actual therapeutics. Two pieces of data came available. One was from one of our peers that for the first time in a 200 plus patients study unequivocally proving that siliciden, which is the active ingredient that comes originally from magic mushrooms, proving that it works in depression and they're paid in helping treat people, people with depression, both the solid and robust resolve at the same time.Simon released data showing that finally after decades, we're able to completely transform this molecule and turn it into something that's actually useless as a therapeutic. The downside visceral assignment historically has been that clinic times are eight hours. So your patients are in the clinic for eight hours a day.And significant side effects and adverse events and would see why B3 we've shown that we can cut this clinic time in half and we can reduce potential for side effects like nausea and headache and other adverse events in half as well. So a major breakthrough. So essentially you're saying that so psilocybin on its own, which, which, like you mentioned, is, um, what's found in magic mushrooms has been proven to help with depression, but there've been downsides, um, to just take an oral.So psilocybin, so with CYB three, you were able to kind of address some of those downsides, um, to, to the actual psilocybin. Exactly. So we've taken psilocybin, we've made it synthetically in the lab and then we've modified it to improve the profile so that it's has a safer profile for patients and pay spend half the time in the clinic.Got it. So, so for some people out there that may have, um, some of these psychological disorder, major depression disorder, um, bipolar, and I know some of them have, have tried a lot of different things and, um, you know, different medicines on the market don't work. So, so is this something that, uh, can be seen as an alternative to helping these patients when those other medicines don't seem effective?Yeah. And once approved they have. So when you look historically back at how we treat depression, we typically use drugs called SSRS, which unlike Prozac. And when you look back over the last couple of decades, on average, a SSRI is typically I know better than placebo in patients with mild to moderate depression and many patients try two or three or more of those Sri's before running out of options.And so a CYB three now provides once it's approved another option for patients to tackle their depression and addiction and anxiety disorder. Did Doug, this has Spencer here. I want to ask you, um, about the, the headline we got late last week, and we're getting again here today about just through the Republican, a bill to legalize cannabis.Uh, I sort of grew up these two things together. I know they're not really technically the same thing, but I sort of look at, um, psychedelics as, as sort of following the cannabis lead in every respect in terms of just regulation and capital markets. Um, I'm wondering if, if, if the move by, by the GOP, if that has sort of changed your, um, changed the, the, the equation at all for a psychedelic regulation at large in the U S.No, not really quite different. So I see that there's a general sentiment change towards looking at these alternative types of treatments and that's all positive. We're looking at drug development that needs to go through the FDA and we're planning studies plan that are coming up in early, early next year.Um, FDA has granted breakthrough therapy status to sub assignment. So they've indicated that this molecule was really potentially important in mental health and da just, uh, came out and said that manufacturers should be making more of these substances to allow more research to be done. So I think we're seeing very positive signs, but DEA and FDA, when it comes to turning these molecules into actual therapeutics that can be prescribed by a physician.So, so Doug is there, uh, you know, a lot of opposition from, I guess, you know, what you could call like big pharma, some of the producers of these SSRS that see, uh, this field as maybe something that's emerging as a competitor to them. So are there, are they, do you see that opposition for big pharma? No. I think the big pharma will see this as an opportunity.When you look across the big pharma space, many of their psychic psychiatry departments have gone over the years. They've become neurology departments. And so there's really been very little innovation in psychiatry in maybe 30 years. So when you look at the total addressable market of all these indications that psychedelic companies are working towards, it's around $300 billion annually.So I think the big pharma will absolutely be interested in this is a space where there's been very little innovation for separately. So Doug for Simon. I mean, I, you know, the namesake comes from psilocybin and mushrooms, but I understand that you're working on other drugs as well. Which other, uh, you know, drugs are you working with outside of psilocybin?Yes. We're working on some other molecules that are related. Uh, these molecules are called tryptamines, which are all like serotonin, which is a naturally occurring. You're a transmitter in your brain. As we're working on some other tryptamines for anxiety disorders. We're also working on a range of molecules called phenethyl means.And these are molecules that are related to MGMA or masculine that might help with PTSD in the future. So we have about 50 molecules in our library currently, and we're taking our lead two candidates into the clinic very shortly. Wow. So, so for investors, you know, our, our, our audience here is mostly retail investors some day traders.What could they be looking out for just in the end, not with cyber in particularly, but just in the industry as a whole, like, are we so early stage that maybe, um, you know, we continue to see some of these names get beaten down or do you think it'll be pretty quickly once we start seeing, okay. People are really noticing that, Hey, look in the psychedelic space, this has actual value and potential, and we can see those investors start coming.Yeah, there has been a bit of a rush over the last couple of years, companies rushing into this space. Uh, but I think we're moving from a period of news to a period of Qaeda. So Simon was one of the first companies sort of the state of this last week. And I think those data points will start to really separate companies from each other and differentiate them.So look out for data. That's coming out of clinical studies over the next six to 12 months, and that'll reset some of these companies apart, I think from some earliest stage organizations that are not quite up to speed yet. Good question here from our chat. Um, how does the FDA's new designation for, for a Simon's work, uh, affect the timeline for commercialization?This is from solar up. Yeah, potentially the breakthrough therapy status, uh, could accelerate the timeline to, to commercialization. There's two things really, uh, the first is that, uh, FDA provides a rolling review. And that just means that they're looking at the data that you submit in real time, not, not in lumps at certain time points, and that's much more efficient.You also get to collaborate with that day and ask questions, which means that instead of guessing what they're looking for, you can take advice on what they're looking for. And typically we breakthrough therapy status to FDA requires perhaps just one phase three study, which are the big expensive studies rather than two.So that can save time and cost of coming to market as well. Got it. So do you have any like ballpark timeline on when you hope to get some of these drugs through the pipeline that the approval? Yeah, so unfortunately drug development is quite slow. Um, but for a reason, the good regaining payments have to be, have to be safe and they have to be tested well so that they can be prescribed for patients.So from where we are today, we're looking at those kind of four to five-year timeframe, still to get through those major critical studies with the first one kicking off in early 20, 22. And then from Brando, likewise, with cannabis or as well as what happened to cannabis, do you foresee it being a case of we get a medical first and recreation and then, and then later on some states doing both at the same time, or, yeah, I don't think so.These are very much going down the pharmaceutical route. And the concept here is that they will be given under supervision or clinical setting and combined with psychotherapy. So patients will go through a period of therapy associated with the treatment, and it seems to be the combination of psychotherapy and the molecule of the drug itself that lead to these good outcomes.Uh, in some studies we've seen that four times, the effect size of SSRI is a four times greater effective at treating depression when combining the psychotherapy, uh, with the molecule. So it's hard to see with this current generation of molecules, uh, that there'll be a recreational. Okay, that makes sense.So, Doug, have you seen a big shift over the last couple of years, just in sentiment regarding, uh, some of these drugs becoming, you know, uh, like viable treatments, because I'm sure, you know, five years ago there would be doctors that scoffed and said, oh, this isn't real medicine, et cetera, but now it seems like more and more people are taking this field seriously.And it's not just doctors. I mean, first of all, psychiatrists are typically fairly open-minded about trying new treatments for their patients, but then you add in the FDA and the DEA throwing their support behind this work. And then also major chip biotech funds. Many of which have invested in Simon are really getting behind this as well.And when you start to see the smart money getting into the space and we know that there's real potential. Got it. So I think one of the, you mentioned that in the last 30 years there hasn't been that much, uh, you know, development or improvement in psychiatric care. Um, and I think one of the problems is that a lot of doctors, you know, see it as, okay, I'm going to prescribe someone, uh, you know, this SSRI and that should help alleviate the symptoms or help solve the problem.But, um, you know, oftentimes a lot of psychiatrists talk about some more holistic measures on top of the medicine. Uh you know, looking at some of these other holistic, you know, things people can do to improve their mental health outside of the drug, or is it simply, um, you're just trying to develop this molecule that you think will be a better.Well, it sounds for the molecule. Let's make sure that these molecules are, have realistic duration that can be scalable and let's make sure they're safe and well tolerated. So we minimize the side effects, but you also want to make sure given the nature of these molecules that they're given in a safe environment.So we've created a psychotherapy program called embark. It takes in six domains of best practice, like a therapy. And we using that to train therapists that will apply to therapy in our clinical trials. And we're making that open source. So therapists can get trained. They want to do that, but also to make sure that we're applying it's like therapy in a consistent way and putting patients in a safe environment.Yeah. I was just curious if that was part of the, I guess quote unquote treatment plan is like, okay, we'll, we'll get, um, this patient on say C Y C Y B3, but that patient should also be getting, I don't know, X amount of hours of sleep a week or exercise, you know, having the other things that help factor into someone's mental health outside of just what drugs they're taking.Yeah, of course. I mean, exercise, eating well, getting good sleep are all good contributors to mental health. When we look back at some of the academic studies that have been performed using psychedelic drugs, uh, those that have reduced or eliminated the psychotherapy have been shown to be less effective.So really does seem to be a combination of the psychotherapy and the drug together. So it forms a kind of a package that helps people overcome the trauma. That's underlying that depression, all. So Doug, what drew you to this industry? I mean, do you have more of a psychiatric background or more of a chemistry background?You know, how did you get here? Yeah, I started out my career in a lab, uh, but I've been in, in, uh, pharmaceuticals in the healthcare industry for 30 years. So I've been developing drugs for, for that time. And, uh, you know, like most of us, you guys too, I'm sure we all know someone in a loved one, family, friends has been affected by depression or addiction.It's tragic as soon as it's all around us. So in 30 years of drug development, I don't think I've had an opportunity in that time to help as many people in such a profound way as we can with the psychedelics. So, so our mission to really turn these into therapeutics once and for all. So, but do you have anything that drew you particularly to psychedelics or was it just that you identified that, Hey, this is a good opportunity here to maybe help tackle some of these problems once and for all the truly groundbreaking.I mean, I can set, I have family and friends have been deeply impacted by this and to be able to combine your work with helping the people that you love is never a bad thing. And it's red, you see data like we see with psychedelics and how profound the effect can be. Literally patients who have spent years of addiction walking away from a psychedelic session and free from those addictive cravings for weeks or months at a time from just one session.I not seen anything like that in my career. So this is an enormous. Got it. Well, Doug, thank you for coming on the show today, we will have to get you back on as Sabin announces more data and news. Um, I know a lot of us here at Benzinga are kind of, you know, following this industry closely and very fascinated by the, um, you know, the progress that has been made so far.Uh, so Doug, thank you again for coming on. Thanks for having me guys. Um, all right. It's one. O'clock we're going to have our next guest on, in his second before I bring them on, though. Uh, AB did you see what Luminari is doing today? L a Z R L a Z R. We had them on the show on Friday and we're up 11% today.Let's go. I'm not saying Benzinga is why Luminari is up 11% today, but I'm also not saying ending is not why. Yeah. I've heard some kids on the street are calling the Benzinga bump. Um, oh, I thought that's something different.I got both errands to live for that one. Oh man. All right. Well, I, I don't even know how to follow that up, so I'm just gonna bring my man Jake on the stream. Jake, how we doing? Hey, how are ya? Thanks for asking what's up. Jake? Who Jasick from trend spider. Jake. I thought of you this morning because we're talking about Grogan and I know that's one of your favorites.So I'm sure you're happy today. I do like it. Yeah. Now I have it as a long-term investment. It's not something I actively trade, so I just keep dollar cost averaging in, but yeah, definitely a nice day kind of a weird market out there. Honestly, got a lot of, uh, what I like to call Christmas colors in the watchlist.You don't really have, you know, a lot of green, a lot of red, it's just kind of just every other stock I have in the watch list is either red or green. So getting the Christmas color vibe there right now, but definitely kind of weird with, with spy is a weekly candle from last week. That's something that does have me a little cautious.I do kind of lighten, lighten some of my positions today. It was a definitely a huge week for me last week in the trading arena. So I definitely don't want to be giving back profits. So, um, I did lighten things up. I still, I think marijuana is probably just getting started, but you know, uh, we have to kind of look at the broad markets before we look at individual names too much.And, and yeah, so with, with spy, I'd really want to, to get above last, week's hide for this to be a little bit of a more risk on sentiment, but Bitcoin is, well, you have this weird pump last night, and now all of a sudden you're back to where we started. So just kind of a weird market. It is OPEX this week.So that's something to keep in mind. Uh, Yeah. So that's, yeah, I'm not in any options positions this week, uh, for that reason, just you, you have some crazy mo

Episode Summary:Will Elon Musk sell 10% of TSLA?IPOs to watch this week RIVNWhy construction management software is the futureGuests:Matt Hammond, IPO Warriorshttps://www.Ipowarriors.comTwitter: https://twitter.com/warrioripoTooey Courtemanche, CEO of Procore (PCOR)Jake Wujastyk, Co-Founder, TrendSpiderTwitter: https://twitter.com/Trendspider_Jhttps://www.trendspider.comCheck out Trendspider.com➡️ Enter promo code BZ25 to get 25%Chris Capre, 2nd Skies Tradinghttps://2ndskiesforex.com/Twitter: https://twitter.com/2ndSkiesForexHosts:Spencer IsraelTwitter: https://twitter.com/sjisraelAaaron BryTwitter: https://twitter.com/aaronbry5Subscribe to all Benzinga Podcasts hereClick here for BENZINGA TRADING SCHOOL Get 20% off Benzinga PRO here Become a BENZINGA AFFILIATE and earn 30% on new subscriptionsDisclaimer: All of the information, material, and/or content contained in this program is for informational purposes only. Investing in stocks, options, and futures is risky and not suitable for all investors. Please consult your own independent financial adviser before making any investment decisions.Unedited Transcript Episode Summary:Buy The Dip in PTON Peloton stock or PENN?Guests:Jon Erlichman https://twitter.com/JonErlichmanTony Benson, Patterns In A Flash 56:00https://wealthbuildershq.com/patterns-in-a-flash-epEvan Mendoza https://twitter.com/e_mendoza18Hosts:Spencer IsraelTwitter: https://twitter.com/sjisraelAaaron BryTwitter: https://twitter.com/aaronbry5Subscribe to all Benzinga Podcasts hereClick here for BENZINGA TRADING SCHOOL Get 20% off Benzinga PRO here Become a BENZINGA AFFILIATE and earn 30% on new subscriptionsDisclaimer: All of the information, material, and/or content contained in this program is for informational purposes only. Investing in stocks, options, and futures is risky and not suitable for all investors. Please consult your own independent financial adviser before making any investment decisions.Unedited Transcript Support this podcast at — https://redcircle.com/zingernation-power-hour/exclusive-contentAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

Episode Summary:On the Benzinga Power Hour, Spencer Israel and Aaron Bry are talking this week's earnings and IPOs and more.Guests:Matt Hammond, IPO Warriorshttps://www.Ipowarriors.com Twitter: https://twitter.com/warrioripoJake Wujastyk, Co-Founder, TrendSpiderTwitter: https://twitter.com/Trendspider_Jhttps://www.trendspider.comCheck out Trendspider.com➡️ Enter promo code BZ25 to get 25%Chris Capre, 2nd Skies Forexhttps://twitter.com/2ndSkiesForexhttps://2ndskiesforex.com/Hosts:Spencer IsraelTwitter: https://twitter.com/sjisraelAaaron BryTwitter: https://twitter.com/aaronbry5Subscribe to all Benzinga Podcasts hereClick here for BENZINGA TRADING SCHOOL Get 20% off Benzinga PRO here Become a BENZINGA AFFILIATE and earn 30% on new subscriptionsDisclaimer: All of the information, material, and/or content contained in this program is for informational purposes only. Investing in stocks, options, and futures is risky and not suitable for all investors. Please consult your own independent financial adviser before making any investment decisions.Unedited Transcript Support this podcast at — https://redcircle.com/zingernation-power-hour/exclusive-contentAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

HALLOWEEN $1,000 GIVEAWAYY TO OUR PRO USERS!Not a Benzinga Pro user? No problem!(No Credit Card Needed!!!)https://benzinga.grsm.io/1000GIVEAWAYEpisode Summary:On the Benzinga Power Hour, Spencer Israel and Aaron Bry are talking AAPL, AMZN, and more.Guests:Ross Gerber, Co-Founder & CEO, Gerber Kawasakihttps://gerberkawasaki.com/https://twitter.com/GerberKawasakiMatt Hammond, IPO Warriorshttps://www.Ipowarriors.com Twitter: https://twitter.com/warrioripoRick Eiswirth CEO Alimera Sciences $ALIMhttps://alimerasciences.com/Jake Wujastyk, Co-Founder, TrendSpiderTwitter: https://twitter.com/Trendspider_Jhttps://www.trendspider.comCheck out Trendspider.com➡️ Enter promo code BZ25 to get 25%Chris Capre, 2nd Skies Tradinghttps://2ndskiesforex.com/Hosts:Spencer IsraelTwitter: https://twitter.com/sjisraelAaaron BryTwitter: https://twitter.com/aaronbry5Subscribe to all Benzinga Podcasts hereClick here for BENZINGA TRADING SCHOOL Get 20% off Benzinga PRO here Become a BENZINGA AFFILIATE and earn 30% on new subscriptionsDisclaimer: All of the information, material, and/or content contained in this program is for informational purposes only. Investing in stocks, options, and futures is risky and not suitable for all investors. Please consult your own independent financial adviser before making any investment decisions.Support this podcast at — https://redcircle.com/zingernation-power-hour/exclusive-contentAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

Enroll in Benzinga Trading School now and get 50% off admission: https://bit.ly/3eQCVgyWelcome to the Benzinga Boot Camp: Transform Your Trades in 1 Day!Chris Capre https://2ndskiesforex.com/Get lifetime access to Benzinga Boot Camps https://events.benzinga.com/video-libraryDisclaimer: All of the information, material, and/or content contained in this program is for informational purposes only. Investing in stocks, options, and futures is risky and not suitable for all investors. Please consult your own independent financial adviser before making any investment decisions.Support this podcast at — https://redcircle.com/first-trade/exclusive-contentAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

Welcome to the Benzinga Boot Camp: Transform Your Trades in 1 Day!Chris Capre https://2ndskiesforex.com/Enroll in Benzinga Trading School now and get 50% off admission: https://bit.ly/3eQCVgyGet lifetime access to Benzinga Boot Camps https://events.benzinga.com/video-libraryDisclaimer: All of the information, material, and/or content contained in this program is for informational purposes only. Investing in stocks, options, and futures is risky and not suitable for all investors. Please consult your own independent financial adviser before making any investment decisions.#Benzinga #Stocks #Trading​ #stockmarketlive #BenzingaProPodcast Topics:benzinga bootcamp,learn to trade stocks,learn to trade options,options trading workshop,benzinga live,learn options trading for beginners,stock market 101,how to invest in stocks,stock market for beginners,stock market,stocks to buySupport this podcast at — https://redcircle.com/zingernation-power-hour/exclusive-contentAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

Welcome to the Benzinga Boot Camp: Transform Your Trades in 1 Day! Chris Capre https://2ndskiesforex.com/ Enroll in Benzinga Trading School now and get 50% off admission: https://bit.ly/3eQCVgy Get lifetime access to Benzinga Boot Camps https://events.benzinga.com/video-library Disclaimer: All of the information, material, and/or content contained in this program is for informational purposes only. Investing in stocks, options, and futures is risky and not suitable for all investors. Please consult your own independent financial adviser before making any investment decisions.

Đăng kí tài khoản sàn Binace để trade Bitcoin : https://www.binance.com/vi/register?ref=12289522 Đăng kí tài khoản sàn Exness để trade forex https://www.exness.asia/a/jeyr09nfjh Đăng kí tài khoản sàn XM nhận $30 Thưởng giao dịch để trade forex: https://clicks.pipaffiliates.com/c?c=554486&l=vi&p=1 BUY ME A COFFEE: hãy DONATE Paypal: blognhadaututhongminh@gmail.com Ví BTC: bc1qf8llfa6fce8anshqdkevfk02z76fvms67x7h2t Ví ETH: 0xe37558ced715db180fb17741db25d7875132d012 Ví BNB: bnb1c3a3rnkta2gngstf4d44nurf7c0vxjgeww8fr9

Đăng kí tài khoản sàn Binace để trade Bitcoin : https://www.binance.com/vi/register?ref=12289522 Đăng kí tài khoản sàn Exness để trade forex https://www.exness.asia/a/jeyr09nfjh Đăng kí tài khoản sàn XM nhận $30 Thưởng giao dịch để trade forex: https://clicks.pipaffiliates.com/c?c=554486&l=vi&p=1 BUY ME A COFFEE: hãy DONATE Paypal: blognhadaututhongminh@gmail.com Ví BTC: bc1qf8llfa6fce8anshqdkevfk02z76fvms67x7h2t Ví ETH: 0xe37558ced715db180fb17741db25d7875132d012 Ví BNB: bnb1c3a3rnkta2gngstf4d44nurf7c0vxjgeww8fr9

Đăng kí tài khoản sàn Binace để trade Bitcoin : https://www.binance.com/vi/register?ref=12289522 Đăng kí tài khoản sàn Exness để trade forex https://www.exness.asia/a/jeyr09nfjh Đăng kí tài khoản sàn XM nhận $30 Thưởng giao dịch để trade forex: https://clicks.pipaffiliates.com/c?c=554486&l=vi&p=1 BUY ME A COFFEE: hãy DONATE Paypal: blognhadaututhongminh@gmail.com Ví Bitcoin: bc1q0ccgj07nt3mfenf5whrh3aspsj669nqj3ht0m2 Ví ETH: 0xc83eA13BA247722A132d93bF52c782cf3bEF0d67 Ví BNB: bnb1c3a3rnkta2gngstf4d44nurf7c0vxjgeww8fr9

Day Trader Mastering Forex, Stocks, and Options In episode 298 of the Desire To Trade Podcast, I sit down with full-time day trader Chris Capre. We discuss a variety of topics that will be very useful if you aspire at mastering Forex, stocks, or options trading in the near future. Don't forget to share this trader interview with other people who might benefit from it! Watch the video interview! Previous Interview with Chris Capre 054: Work Harder On Your Mindset Than You Do On Your Strategy Previous interview with Jason Graystone (#131) Topics Covered In This Episode 0:15 Introduction 0:29 How Chris Capre trading has changed since his last interview with Etienne 5:35 Chris trading philosophy for all asset classes 7:14 Would Chris trade the same assets if he was in different time zones? 8:14 How was Chris learning curve from FX, to Stocks to Options 11:03 How Chris learned to trade Options 14:58 How Chris decides which market to trade every day 18:38 What tools Chris uses to filter the stocks he trades 20:40 Chris advice to traders who want to stick to 1 market 23:25 How to get a good "scanner" for forex [For the screen share please check the youtube video interview] 25:30 How Chris prepares and filters his trades (screen share) 27:45 Analysis of NMRD, how Chris traded it and the value of a scanner 31:20 How to use options to get paid in trading (with trade example) 36:24 How can you manage your risk using options 42:28 How Chris sometimes enters options trades without a spot position 43:38 How to get started with trading options 45:55 The key importance of adapting to the market and much more What is one thing you are going to implement after listening to this podcast? Leave a comment below, or join me in the Facebook group! Desire To Trade's Top Resources DesireToTRADE Forex Trader Community (free group!) Complete Price Action Strategy Checklist One-Page Trading Plan (free template) Recommended brokers: Pepperstone (use our link to get a special bonus) AxiTrader (use our link to get a special bonus) Desire To TRADE Academy How To Find Chris Capre? 2ndSkiesForex Facebook Twitter What is one thing you are going to implement after listening to this podcast episode? Leave a comment below, or join me in the Facebook group!  

Chris Capre, CEO & Head Trader, 2ndSkiesForex.com is on Benzinga Global Small Cap Conference to talk about Healthcare Trends and How to Trade Them.Support this podcast at — https://redcircle.com/zingernation-power-hour/exclusive-contentAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

In this episode, Chris Capre from 2nd Skies Forex talks about an often overlooked but essential part of becoming a successful trading - mastering the psychology. Capre discusses some of the most common trader mistakes and the importance of mindset. He says achieving anything requires FIRE - focus, intention, repetition and emotion and explains why being interested in trading is very different to being passionate about it. Capre also talks about limiting believes, explaining what they are and how to break through them. Any opinion, news, research, analysis, or other information does not constitute investment or trading advice. Follow us on Twitter @IGTV @2ndSkiesForex

Hablemos sobre las estrategias de breakout en divisas ¿Cómo puedo hacer trading en estos momentos? Al operarlos ¿cómo puedo evitar las rupturas en falso? Chris Capre nos lo muestra.Artículo publicado en Hispatrading Magazine nº43. https://www.saladeinversion.com/articulos/breakout/

Subscribe to How To Trade ItChris Capre has a unique background that you would’ve never guessed would transition to trading. After obtaining degrees in philosophy and neuroscience, he moved to California to teach Yoga. He began to dabble with investing in stocks and mutual funds. During that time, a client introduced him to Forex trading. Something about Forex clicked with him—so he dove in. Now, Chris Capre is a successful forex and stock trader and the CEO of 2ndSkies Trading. Listen to this episode of How To Trade It for his compelling story. You’ll want to hear this episode if you are interested in...[1:00] Chris’s background in philosophy and neuroscience.[9:57] What it was like working for FXCM as a trade broker.[14:26] How Chris made the transition to a hedge fund.[17:32] The best route to ease into trading. [27:53] WHY Chris transitioned into stock trading.[34:54] How the switch will impact his community.[37:05] Connect with Chris Capre.Resources & People MentionedFXCMBOOK: Ugly AmericansConnect with Chris Capre2ndSkies Forex2ndSkies on YouTubeConnect With Casey StubbsWebsite: https://caseystubbs.comSubscribe! https://www.youtube.com/caseystubbsTwitter: https://www.twitter.com/caseystubbsFacebook: https://www.facebook.com/caseystubbsLinkedIn: https://linkedin.com/in/caseystubbsNewsletter: https://financeandmarkets.com/Subscribe to How To Trade ItSupport the show (https://caseystubbs.com)

In this episode, Chris Capre, daytrader and swingtrader, founder of 2ndSkiesForex, talks about his journey from yoga and meditation teacher to trader. Capre discusses the mental advantage of his ability to stay present that gives him an edge in the markets. He explains how he started out trading just four currency pairs and has now evolved to trades across stocks, indices, forex and options. Capre says he tends to do better when there is more volatility but after the recent rally, he thinks the markets are looking very vulnerable, especially in the case of a second wave of COVID-19. 00:00 - Entry into financial markets 05:15 - Trading psychology 07:50 - Momentum trading in volatile markets 10:00 - Has the stock market become a retail traders' market? 13:20- Where is the market heading in the future? Any opinions, news, research, analysis or other information does not constitute investment or trading advice. Find us on Twitter: @IGTV

The fields of Artificial Intelligence (AI) and biodata are creating some exciting opportunities for both hedge funds and independent traders. The post EP29 // NeuroTrader: Using Biodata and AI to Boost Trader Performance with Chris Capre and Ken Medanic appeared first on Trading Heroes.

Full-Time Day Trader Secrets and Tricks In episode 172 of the Desire To Trade Podcast, I am sitting down with pro trader Chris Capre and Ken, an expert in neuroscience to discuss some neuroscience trading secrets. In this podcast, we talk about some mind-blowing things about neuroscience and hedge funds, trading for other people, and what the different solutions are for that. Watch the video here.    Topics Covered In This Episode Who Chris Capre, what he does, and where he is from [0:44] Why you cannot focus only on strategies, and why you need more in order to succeed [8:26] What Chris did before trading for other people [14:36] Learning things with the right traders and taking the right courses [16:57] How to deal with long periods of no trading [22:30] What the steps in changing strategies in different markets are [29:08] Who Ken is and his background in trading [32:24] Using the Neuro Trader program and how it affects success rate [38:58] Why it’s good to have a coach and not get rid of him/her [43:04] What signals Chris and Ken look for to determine if someone is not in his peak performance [44:32] Why you should protect your psychological and financial capital at the same time [53:11] What the Neuro Trader Program is about [59:54] Getting quantified feedback data from the program [63:25] What the cost and requirements when you join the Neuro Trader Program are [71:11] Meeting the “1% average” for the total six-month period requirement [79:50] Why money is the not the problem, but it’s your commitment [82:11] Why investing in yourself is the best investment you can always make [84:43] Resources Mentioned Neuro Trader Program  Learn more how to trade for the hedge fund   DesireToTRADE Top Resources Desire To TRADE Forex Trader Community (free group!) Complete Price Action Strategy Checklist (free checklist!) One-Page Trading Plan (free template!) DesireToTRADE Academy (exclusive training program) How To Find Chris Capre? Website: 2ndSkiesForex.com Twitter: @2ndSkiesForex   What is one thing you are going to implement after listening to this podcast episode? Leave a comment below, or join me in the Facebook group!

In just minutes from now, you can be listening to my full 82 minute interview with Chris Capre. Plus  get 15% off Chris Capre’s Advanced Price Action Course. using Promo Code: 52TRADERS15  How much would you pay to spend an hour with a trader of this caliber? Chances are, you’d never get the chance, but in just minutes from now, you will! And as a special bonus, you will also get 30 days of FREE access to my entire library of interviews with over 100 of the world’s best traders and it's only $5! Click Here To Start Learning From The World’s Best Traders Frequently Asked Questions Q: Can I listen on my Smartphone like a normal Podcast? A: Yes, you can download episodes and listen on Apple’s Podcast App, the Overcast App or on Android’s Podcast Addict App. Q: How often do you release new interviews? A: I promise  up to 4 new interviews a month, sometimes more. Q: Can I listen to the interviews online? A: Yes, when you are logged into your Pro Membership you can see all the show notes and listen to the interviews. Q: Where can I see the charts and videos left by the traders?A. When you are logged into your Pro Membership you can see all the show notes below the player. Q: Can I cancel the subscription at any time? A: Yes, you can cancel at any time via the members area.

Order Flow Forex Trading & Price Action In episode 143 of the Desire To Trade Podcast, I interview pro trader Chris Capre from the US. He is also the founder of 2ndSkiesForex and a soon-to-be new trading venture. In this podcast, Chris went a little bit more in detail on his professional methods and most specifically how he uses order flow in trading. He also shows his approaches and methods through charts/graphs in this episode. Topics Covered In This Episode Who Chris is, what he does, and background on his trading [1:47] Chris' trading style, price action, and order flow [5:13] How to read and understand order flow [11:24] What Chris looks at in the model [19:38] The challenges and not getting overwhelmed with the data [24:24] The best way to look at the chart [28:33] Bullish and bearish candlestick patterns [30:42] The timeframe to consider [34:29] How Chris uses or integrates news and fundamental data or sentiment into price action [36:48] Chris' goals for profit per month and how he measures it [40:12] How Chris sets targets and risk parameters [42:59] How Chris uses indicators [45:16] Ichimoku Cloud and the ways to trade it [45:42] Chris' Price Action Course [50:42] Chris' techniques for withdrawals in your account and equity management [53:04] Chris' advice for people [58:15] Resources Mentioned Chris Capre's Advanced Price Action Course (Use promo code EC15OFF to get 15% off the course.)   DesireToTRADE Top Resources Desire To TRADE Forex Trader Community (free group!) Complete Price Action Strategy Checklist (free checklist!) One-Page Trading Plan (free template!) DesireToTRADE Academy (exclusive training program) How To Find Chris Capre? Website: 2ndSkiesForex.com Twitter: @2ndSkiesForex What is one thing you are going to implement after listening to this podcast episode? Leave a comment below, or join me in the Facebook group!

In episode 87 of the Desire To Trade Podcast, we discuss exactly what you need to know to increase your trading capital as I interview Forex trader Raj Turner based in Kingston, Jamaica. More about Raj Turner Outside his trading, Raj is a trained Engineer & Certified Supply Chain Manager. As a trader of the major pairs in the Foreign Exchange Market, he looks for swing trades (medium term) as that's what he believes to be most profitable. He got in the market or the first time about 10 years ago and has recently won 7x the TopTradr financing for $10,000 Learn About TopTradr A couple of weeks ago, I was approached by someone from TopTradr and I liked the concept of their app, so I thought I'd include a small description of what they do with this podcast episode... TopTradr is a companion app for your trading. It's designed to give you greater scope to realize your ambitions. By linking an MT4 account from one of their recommended brokers, the app ranks your profile versus other traders for a chance increase your trading capital and manage a $10,000 prop account. It's very easy to get involved: first create your profile, then link a trading account via a recommended broker and you can start trading. >> Check Out TopTradr I'd love if you can take a few seconds to leave a review on iTunes or Stitcher. Let me know honestly what you think of the podcast because the only way I can improve is through your reviews. Share This!   In This Episode, You'll Learn... What a typical day looks like in the life of Raj Managing to trade profitably with a full-time job What TopTradr is about The steps Raj had to go through to see consistency in his trading The few things "hobby traders" have to overcome to get profitable How to increase your trading capital progressively The beauty of trading a bigger account Simplifying your trading strategy to remember it easier The power of being in a supportive community And much more! What is one thing you are going to implement after listening to this podcast? Leave a comment below, or join me in the Facebook group! Resources Mentioned In This Episode Risk Of Ruin Calculator: I use the one from Chris Capre all the time! DesireToTRADE's Top Resources DesireToTRADE Forex Trader Community (free group!) Complete Price Action Strategy Checklist (free checklist!) One-Page Trading Plan (free template!) DesireToTRADE Academy About The Desire To Trade Podcast Subscribe via iTunes (take 2 seconds and leave the podcast a review!) Subscribe via Stitcher Subscribe via TuneIn Subscribe via Google Play See all podcast episodes

Chris Capre: Work Harder On Your Mindset Than You Do On Your Strategy Read the show notes In episode 54 of the Desire To Trade Podcast, I interview Chris Capre, a Buddist, trader (Forex & Futures), and philanthropist. He’s the man behind 2ndSkiesForex. I personally consider Chris as a leader in the trading industry. What’s more, he created a useful framework that any trader can follow to see results in trading. Chris was fortunate to experience great success very early in his trading career, but eventually realized he hadn’t done things intelligently. One day during the London session, he lost $15,000. That was an important changing moment for him. During his interview, Chris and I discussed some of the pillars to successful trading. Overall, your success comes down to how you handle the Technical, Mindset, and Money Management aspects of trading.   Question & Cheat Sheet – Chris Capre Why Chris trades the Asian session & how he does it How he was able to succeed quickly in trading and lost $15,000 in a single day! The 3 aspects trader must master for success The pyramid with Technical, Mindset, and Risk Management. How going against the majority of traders can make you successful How to develop the mindset to trade a bigger trading account That’s where neurolasticity & loss aversion come into play. And much more!   What is one thing you are going to implement after listening to this podcast? Leave a comment below, or join me in the Facebook group! ————————————————————————————————————————————— Special Offer For The Listeners Get 15% Off Chris’ Advanced Price Action Course Course: click on this link and enter coupon code “EC15OFF” at checkout. —————————————————————————————————————————————

There is more to Forex trading than just analyzing the charts. Doesn't matter whether you are a short term or a long term trader, if you don't have the right mindset, you'll not get the results you want. Today, I'm happy to welcome Chris Capre from 2ndSkiesForex. Chris is a Buddhist, Trader and a Philanthropist. He joins us today to share his Forex journey and some great insights us on becoming a successful Forex trader.  

We are back! In this interview, I talk to professional trader and mentor Chris Capre and find out how he went from wanting to become a Yoga teacher to trading Forex. This is a long interview with a ton of great information, so be sure to have a notepad ready. The post Chris Capre: This Transformed Him Into a Pro FX Trader From a Yoga Teacher // EP12 appeared first on Trading Heroes.